Genomic instability can trigger cellular responses that include checkpoint activation, senescence and inflammation 1, 2 . Although genomic instability has been extensively studied in cell culture and cancer paradigms, little is known about its effect during embryonic development, a period of rapid cellular proliferation. Here we report that mutations in the heterohexameric minichromosome maintenance complex-the DNA replicative helicase comprising MCM2 to MCM7 3, 4 -that cause genomic instability render female mouse embryos markedly more susceptible than males to embryonic lethality. This bias was not attributable to X chromosomeinactivation defects, differential replication licensing or X versus Y chromosome size, but rather to 'maleness'-XX embryos could be rescued by transgene-mediated sex reversal or testosterone administration. The ability of exogenous or endogenous testosterone to protect embryos was related to its anti-inflammatory properties Chaos3 helicase mutant. Our experiments indicate that, during development, DNA damage associated with DNA replication induces inflammation that is preferentially lethal to female embryos, because male embryos are protected by high levels of intrinsic testosterone.
. Ibuprofen, a non-steroidal anti-inflammatory drug, rescued female embryos that contained mutations in not only the Mcm genes but also the Fancm gene; similar to MCM mutants, Fancm mutant embryos have increased levels of genomic instability (measured as the number of cells with micronuclei) from compromised replication fork repair 6 . In addition, deficiency in the anti-inflammatory IL10 receptor was synthetically lethal with the Mcm4 Chaos3 helicase mutant. Our experiments indicate that, during development, DNA damage associated with DNA replication induces inflammation that is preferentially lethal to female embryos, because male embryos are protected by high levels of intrinsic testosterone.
Mutations that compromise DNA replication or replication-associated repair can cause replication stress and genomic instability 7, 8 . The resulting chronic DNA damage can lead to inflammation by activating the cGAS-STING pathway, potentially resulting in a senescenceassociated secretory phenotype 1, 9, 10 . Little is known about the consequences of fetal or maternal inflammation induced by genomic instability during gestation.
DNA replication requires minichromosome maintenance complex (MCM) 2 to MCM7 (hereafter, MCM2-7), which constitute the catalytic core of the replicative helicase. Reduction of MCMs causes replication stress by decreasing the number of dormant origins, which are important for completing DNA replication when replication forks stall or collapse [11] [12] [13] .
Mice that bear the Chaos3 allele of Mcm4 (hereafter, Mcm4

C3
) have increased numbers of cells with micronuclei, and are highly prone to cancer 4 . This allele causes genomic instability by destabilizing MCM2-7, and triggering post-transcriptional pan-reduction (about 40%) of the C3 homozygotes in strain C3H are fully viable, compound heterozygosity for some of the other Mcm genes has severe phenotypic consequences, including pre-and postnatal lethality 3 . Upon closer examination of these and additional breeding data, we noticed that female mice of the MCM-depleted, semi-lethal genotypes 
Mcm6
Gt/+ and Mcm4
C3/C3
Mcm7 Gt/+ (in which Gt denotes the gene trap allele) were markedly under-represented compared with males of the same mutant genotype (Fig. 1a, Supplementary Tables 1-4 ). There was no sex skewing associated with non-lethal genotypes (Mcm4
Mcm3
C3/C3
Mcm5
Gt/+ )-that is, these non-lethal genotypes present in offspring at Mendelian ratios 3 ( Fig. 1a , Supplementary 
Mcm2
Gt/+ female mice, respectively) 3 . We next hypothesized that the female-biased embryonic lethality was related to one of the following: (1) defects in X chromosome inactivation caused by impaired or delayed DNA replication; (2) 
Gt/+ mice from 20% to 48% (Fig. 2a, Supplementary Table 6 ). These results indicate that maleness-and not the presence of only one X chromosome per se-protects embryos from MCM deficiency. These data are consistent with the finding that the preferential death of female embryos occurs after sex determination (E9.5-E12.5).
Because sex reversal rescued the preferential lethality of XX embryos, we hypothesized that testosterone might be responsible. Testosterone Letter reSeArCH is produced at high levels by Leydig cells in embryonic testes from approximately E12.5 onward 16 . Beginning at E7.5, we injected pregnant females daily with testosterone and found that the viability of XX Mcm4
C3/C3
Mcm2
Gt/+ E19.5 fetuses increased markedly from 22% to 54% (Fig. 2a, Supplementary Table 7 ). We speculated that testosterone might protect MCM-deficient embryos by increasing replication capacity, given a previous report that the androgen receptor stimulates proliferation of prostate cancer cells by acting as a replication factor 17, 18 . However, we observed no increase in any of the Mcm mRNAs or chromatin-bound MCMs in testosterone-treated mouse embryonic fibroblasts (Fig. 2b, c) , and no sex-specific differences in the levels of MCM2 or MCM4 protein in E13.5 fetuses or placentae of various genotypes (Extended Data Fig. 2) .
Next, we hypothesized that testosterone might be ameliorating particular consequences of genomic instability in the MCM mutants. In particular, increased numbers of cells with micronuclei-the signature phenotype of Mcm4 C3 mice 4 -can trigger inflammation via the cGAS-STING pathway 19 . Testosterone, a steroid hormone, suppresses the expression of pro-inflammatory cytokines and increases the expression of the anti-inflammatory molecule IL10 5, 20, 21 . Indeed, testosterone treatment of Mcm4
C3/C3
Mcm2
Gt/+ mouse embryonic fibroblasts decreased mRNA expression of the pro-inflammatory cytokines IL6 and PTGS2 (also known as COX2)-which is central for the production of prostaglandins that cause inflammation and pain-by over twofold and over threefold, respectively (Fig. 2b) . Notably, administration of ibuprofen in drinking water to pregnant females, from 7.5 days after coitus onward, completely abolished the sex bias in the viability of 
Gt/+ offspring (Fig. 2a , Extended Data Table 1a) , without affecting the levels of MCM in the embryo or placenta (Extended Data Fig. 2b, c) .
Although these data indicate that inflammation driven by genomic instability underlies the preferential lethality of female embryos, we also considered the possibility that unrelated alterations in gene expression, caused by ibuprofen and the androgen receptor 22, 23 (which is strongly induced by testosterone; Fig. 2c) , were responsible. 
Mcm3
Gt/+ Mcm6 Gt/+ , P = 0.018) in terms of the ability of Mcm3 heterozygosity to decrease sex bias. b, Timing of female death during embryogenesis. Numbers above bars indicate the viable XY:XX embryos genotyped (these numbers sum to the n values given beneath the bars). P values were determined from χ 2 probability. We therefore took an orthogonal approach, increasing inflammation by ablating the receptor (Il10rb) for the anti-inflammatory molecule IL10 on the grounds that this should exacerbate Mcm4
Mcm2
+/− lethality or increase sex bias. Under conditions of inflammation, IL10 mediates a feedback loop to induce the degradation of Ptgs2 (also known as Cox2) transcripts 24 , and counters the inflammation response triggered by the STING pathway 25 . 
Il10rb
−/− caused highly penetrant lethality to embryos of both sexes (Extended Data  Table 1c ). This synthetic lethality was rescued by treating pregnant dams with a non-steroidal anti-inflammatory drug (NSAID); NSAID treatment increased the viability of Mcm4
C3/C3
Il10rb
−/− offspring (of both sexes) from 8.9% to 94% (Extended Data Table 1c) .
Successful pregnancy requires suppression of inflammation at the maternal-fetal interface. Because homozygosity for Chaos3 alone causes an approximately 20-fold increase in micronucleated erythrocytes without decreasing viability in the C3H background 4 , and because IL10 is thought to have a role in suppressing maternal inflammation at the fetal-maternal interface 26 , we speculated that maternal genotype might influence the viability of MCM compound-mutant embryos. Here, we mated females heterozygous for 
Mcm2
Gt/+ females (Fig. 3a , Extended Data Table 1b ). We hypothesized that maternal homozygosity for Chaos3 imposes additional stress on the placentae of genetically susceptible female embryos, possibly via inflammation induced by DNA damage. We examined the level of double-strand breaks (marked by γH2AX) in the placentae of E13.5 embryos in various control and mutant reciprocal crosses. Regardless of fetal genotype, placentae from embryos within Mcm4 C3/C3 dams had more γH2AX-positive cells than did the placentae of embryos from dams of any other genotype (Fig. 4) . Treatment with an NSAID did not reduce the level of γH2AX staining, which is consistent with our supposition that the rescue effect is related to inflammation rather than to genomic instability per se (Fig. 4) . We therefore hypothesized that placental inflammation induced by genomic instability might underlie the lethality in our mice. Consistent with this, we observed significant reductions in placental-but not embryonic-MCM2 and MCM4 (especially in MCM4) in Chaos3-mutant genotypes, regardless of maternal genotype or whether the dams were treated with an NSAID (Extended Data Fig. 2a-c) . Thus, placental cells may be particularly sensitive to DNA replication defects that trigger the downregulation of MCM production, and to consequent increases in genomic instability and inflammation 27, 28 . 
Gt/+ female embryos from Mcm4 C3/C3 dams (Fig. 3b, Extended Data Fig. 3 ). The major upregulated gene sets included epithelial-to-mesenchymal transition (EMT) (which is commonly associated with inflammatory responses 29 ), allograft rejection and interferon-γ response. All three of these categories contain genes that are involved in inflammation and the innate immune response (Extended Data Fig. 3 ). Overall, our results indicate that the combination of maternal and fetal genomic instability causes lethal levels of inflammation. However, it remains possible that there may be an epigenetic component (that is, imprinting) to the parentalgenotype-dependent and sex-biased lethality.
Although the data presented thus far demonstrate that MCM depletion (for example, Mcm2 hemizygosity)-in conjunction with a destabilized replicative helicase-in Chaos3 mice triggers inflammation and embryonic death, it is unclear exactly which defects are primarily Letter reSeArCH responsible or whether the sex-biased phenomena are entirely unique to these models. We therefore attempted to determine the key proximal defects that trigger the sex bias by exposing wild-type embryos either to exogenous replication stress alone, or to double-strand breaks alone. Pregnant female mice that were treated with hydroxyurea to induce replication stress delivered pups without significant sex skewing (at a maleto-female ratio of 1.08; Supplementary Table 8) . Chronic exposure to ionizing radiation, which causes double-strand breaks, also failed to produce a sex bias (a male-to-female ratio of 1.00; Supplementary Table 8 ). We then conjectured that the replication-associated DNA damage that causes micronuclei might underlie inflammation-driven lethality. Mice deficient in FANCM-which is involved in DNA replication fork repair-display increased numbers of cells with micronuclei 6 , and an underrepresentation of females 30 . We also observed a bias against Fancm −/− females in heterozygote crosses (a male-to-female ratio of 1.68; χ 2 P = 0.03; Fig. 1a , Extended Data Table 1d ) that was rescued by treatment of the dams with ibuprofen (a Fancm −/− maleto-female ratio of 1.13, versus a Fancm +/+ male-to-female ratio of 1.07; Fig. 2a , Extended Data Table 1d ).
Our results indicate that DNA damage brought about by defective DNA replication and/or replication-associated repair causes a level of inflammation that compromises female embryos that lack the antiinflammatory protection of testosterone. We hypothesize that because both of the genetic models we tested have increased numbers of cells with micronuclei, which is a known trigger of the cGAS-STING cytosolic-DNA-sensing pathway, this increase may precipitate lethal inflammation in a key compartment(s) of the embryo and/or uterine environment. Future experiments using mouse mutants and mosaics will help to resolve these questions, and guide studies into whether similar phenomena occur in humans.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-0936-6.
MEthodS
Mice. All breeding and husbandry crosses were performed in the same animal facility and room at Cornell's Veterinary College (East Campus Research Facility), and under the same environmental conditions and health status. The use of mice complied with all relevant ethical regulations, having been conducted under a protocol (0038-2004) approved by Cornell University's Institutional Animal Care and Use Committee. Sample sizes for original sexskewing observations were not planned (because they were taken from historical colony breeding data); the selection of individuals was entirely genotype-based and thus not randomized. Sexing of mice was done before genotyping, and thus there was no blinding. Sample sizes with testosterone and ibuprofen were also not pre-determined, as the potential effect size was unknown (yet proved to be marked).
Testosterone injections and sex reversal. Mcm4 C3/C3
Mcm2
Gt/+ males were mated to Mcm4 C3/C3 females, and 100 μl of a 3 mg/ml solution of testosterone propionate (Sigma) was injected subcutaneously into the hind leg of pregnant females daily from E7.5 to E.16.5 (20 μg per g per day). This dose has previously been shown in a rodent model to increase female fetal testosterone levels by 80% without serious toxicological effect 31 . The testosterone propionate was dissolved in corn oil and filter-sterilized before injection. Mouse embryonic fibroblasts were derived from E13. 5 females and, at E7.5-E9.5, the pregnant females were provided with water bottles containing ibuprofen (children's Advil), 5 ml (100 mg) in 250 ml. Il10rb +/− females, and provided with ibuprofen as described above. Newborn mice were genotyped with primers for Il10rb (Supplementary Table 9 ). Genotyping. Genomic DNA was isolated from mouse tissue using the hot-shot lysis procedure 33 . Genotyping PCR was carried out using Taq1 and gene-specific primer pairs (Supplementary Table 9 ). For Chaos3 genotyping, the PCR products were digested with MboII to identify mutant alleles as Chaos3-but not wild-type alleles-are digestible with this enzyme. For Mcm5, embryonic stem cells were verified using primers that contained regions outside of the gene trap insertion. To determine the sex of early embryos, primers for Sry were used to identify males; females are Sry-negative. Genotyping for Mcm2 to Mcm7 gene traps has previously been described 3 . /J blastocyst donors to generate chimaeras. Disruption of Mcm5 was confirmed by PCR as described in 'Genotyping' (see also Supplementary Table 9) . Following germline transmission, the mutation was backcrossed into C3H for ≥ 4 generations before crossing to C3H-Mcm4 C3 mice. Generation of Fancm mice. Fancm em1/Jcs was generated using CRISPRCas9-mediated genome editing. In summary, an optimal guide sequence that targets the first exon of Fancm was designed using https://zlab.bio/guidedesign-resources/. Oligonucleotides to generate the single-guide (sg) RNA DNA template were ordered from Integrated DNA Technologies and the sgRNA was in vitro transcribed as previously described 34 (CRISPR-FancF: GAAATTAA TACGACTCACTATAGGCCAGCTGGTAGTCGCGCACGGTTTTAGAGCTAG AAATAGC, CRISPR-FancR: CAAAATCTCGATCTTTATCGTTCAATTTT ATTCCGATCAGGCAATAGTTGAACTTTTTCACCGTGGCTCAGCCACGA AAA). Embryo microinjection into C57BL/6J zygotes was performed as previously described 35 , using 50 ng/μl of sgRNA and 50 ng/μl of Cas9 mRNA (TriLink Biotechnologies). The resulting 7-bp deletion was identified using Sanger sequencing, and subsequent genotyping was performed with primers sets specific to the mutant and wild-type alleles (Supplementary Table 9 ). Flow cytometry to monitor X chromosome inactivation. A transgenic mouse 36 containing an X-chromosome-linked GFP transgene was crossed to Mcm4 C3 mice, and fluorescence-activated cell sorting analysis of embryos was carried out as previously described 36 .
Generation of
Mcm4
C3/+
Mcm2
Gt/+ males bearing a ubiquitously expressed X-chromosome-linked GFP transgene were bred to Mcm4 C3/C3 females. E10.5
female embryos (littermates from 7 different pregnancies)-all of which must bear the GFP transgene-were genotyped, dispersed into single cells and analysed by flow cytometry to determine the fraction of GFP + cells. The theoretical maximum of GFP + cells in controls is 50%. Quantitative PCR with reverse transcription. RNA was isolated from cells using a kit as per the manufacturer's instructions (Zymo or Qiagen RNeasy). Five hundred nanograms of RNA was reverse-transcribed into cDNA using qScript (Quanta), and analysed on an ABI7300 or a Bio-Rad CFX96 using the following primers and iTaq (Bio-Rad). All reactions were normalized to Gapdh and/or Tbp. Supplementary Table 10 . RNA-seq. Total RNA was isolated from E13.5 placentae by homogenizing placentae in RNA lysis buffer followed by column purification, as per the manufacturer's instructions (Omega Biotech). RNA sample quality was confirmed by spectrophotometry (Nanodrop) to determine concentration and chemical purity (A260:A230 and A260:A280 ratios) and with a Fragment Analyzer (Advanced Analytical) to determine RNA integrity. Ribosomal RNA was subtracted by hybridization from total RNA samples using the RiboZero Magnetic Gold H/M/R Kit (Illumina). Following clean-up by precipitation, rRNAsubtracted samples were quantified with a Qubit 2.0 (RNA HS kit; Thermo Fisher). TruSeq-barcoded RNA-seq libraries were generated with the NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs). Each library was quantified with a Qubit 2.0 (dsDNA HS kit; Thermo Fisher), and the size distribution was determined with a Fragment Analyzer (Advanced Analytical) before pooling. Libraries were sequenced on a NextSeq500 instrument (Illumina). At least 20 million single-end 75-bp reads were generated per library. For analysis, reads were trimmed for low quality and adaptor sequences with cutadapt v.1.8 using parameters: -m 50 -q 20 -a AGATC GGAAGAGCACACGTCTGAACTCCAG-match-read-wildcards. Reads were mapped to the mouse reference genome or transcriptome using TopHat v.2.1 with the parameters: -library-type = fr-firststrand-no-novel-juncs -G <ref_genes. gtf>. For gene expression analysis, Cufflinks v.2.2 (cuffnorm/cuffdiff) was used to generate values for fragments per kilobase of transcript per million mapped reads (FPKM), and for statistical analysis of differential gene expression 37 . For the gene set enrichment analysis, all expressed genes were analysed using the hallmarks dataset 38 . C3/C3 dams. Immunoblotting. Protein was isolated from E13.5 placentae and embryos by acetone precipitation from RNA-isolation buffer (Buffer RLT or TRK) and resuspending in SUTEB loading buffer (8 M urea, 1% SDS, 10 mM EDTA, 10 mM Tris-HCl, pH 6.8). Protein lysates were run on 4-20% acrylamide gels for sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred to PVDF membrane (Millipore). Immunoblots were probed with anti-MCM2 (Epitomics/Abcam), anti-MCM2 (Cell Signaling Technology), anti-androgen receptor (Epitomics/Abcam), anti-SMAD2/3 (Cell Signaling), anti-p21 (Santa Cruz), anti-MCM4 (Cell Signaling Technology) and anti-actin (Sigma). Secondary antibodies used included goat antirabbit-HRP (Cell Signaling) and goat anti-mouse-HRP (Sigma). Crescendo ECL substrate (Millipore) was used, and immunoblots were digitally scanned using a cDigit scanner. Quantification of immunoblots was performed using ImageStudio software. γH2AX staining. Placentae from E13.5 embryos were dissected from individual embryos and washed in PBS. Decidua were separated from the placenta and uterine tissue with fine forceps. Genotyping was carried out using a piece of the embryo. Placentae were flash-frozen in OCT and 10-μM sections were cut on a cryostat and affixed to slides. Sections were fixed for 10 min with 4% paraformaldehyde in PBS, and stained with mouse anti-γH2AX-phospho Ser41 (Millipore) using a Mouse On Mouse kit and biotin-streptavidin blocking kit (Vector Labs), according to the manufacturer's instructions. Alexa Fluor 488 or Alexa Fluor 647-streptavidin (Invitrogen) was used for visualization. Slides were scanned using a Scanscope FL with a 20× objective. Images were quantified using Fiji or HALO (Indica Labs), and foci were detected as described 39 with an added size parameter to differentiate between nuclei and cytoplasmic signals 40 .
Primer sequences for
Hydroxyurea and irradiation treatment of embryos. For irradiation experiments, pregnant females were irradiated with 5 rads (50 mGy), 3 times a week during gestation, beginning at E1.5. For hydroxyurea experiments, hydroxyurea (Sigma) was dissolved at 10 mg/ml in sterile 1× PBS for injection. Pregnant C3H females were subjected to daily intraperitoneal (i.p.) injections of 30-50 μg per kg, beginning at E3.5. Control females received daily i.p injections of sterile 1× PBS alone. All pregnancies were carried to term, and the number and sex of the mice was determined at birth. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
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Data availability
All data that underlie the findings of this study are presented in the paper, except for RNA-seq data, which have been deposited in the GEO database under accession number GSE119710. Source data are provided with the paper for the γH2AX and MCM protein quantifications. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Data analysis GSEA(v3.0) is freely available from the Broad institute and was used in the analysis of expressed genes from the RNAseq datasets. Graphs and statistical analysis was carried out using Prism 7. FIJI(v2.0) is a freely available version of ImageJ and was used in image analysis. HALO (Indica Labs) was used to quantify nuclear signals in scanned slide images. ImageStudio (Li-Cor v5.2.5) was used to quantify western blot scans.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
Reagents available upon request. The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article. RNA-seq data has been deposited into the GEO database (accession number GSE119710).
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Sample size
We performed a power analysis to determine the minimum number of animals necessary to determine an effect. To reduce the overall number of animals required to determine if there was a significant effect, we estimated the expected ratio of sex and genotype from matings to provide a guide.
Data exclusions
All animals from each described mating was genotyped and included in the presented data. There were no exclusions.
Replication
The primary finding of a female sex bias was verified by two separate investigators performing similar experiments several years apart in the same facility and with the same mouse strains. The findings have been reproduced repeatedly over several years. All other experiments involving biological specimens were carried out a minimum of 3 times to verify reproducibility using biological replicates.
Randomization No randomization was used as every animal was individually genotyped and the overall number of each genotype checked against the expected number from each mating.
Blinding
No investigator blinding was used as every animal in every litter was individually genotyped and the overall number of each genotype checked against the expected number from each mating.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Validation
All antibodies and validation information are provided on the manufacturer's websites and can be located using the provided catalog numbers.
Eukaryotic cell lines Policy information about cell lines
Cell line source(s)
Mouse embryonic fibroblasts were isolated from E13.5 embryos of the indicated genotypes.
Authentication
As the cells were primary cells, isolated and utilized specifically for this work by the authors, no additional authentication was necessary.
